An aminoglycoside and three tetracyclines, with some designed to overcome resistance.
New HIV Antiretrovirals
New ARTs include a first-in-class postattachment inhibitor and fixed-dose combinations that provide complete drug regimens.
Other New Antimicrobials
New antimicrobials for influenza, malaria, onchocerciasis, smallpox, and more.
New Drugs for Migraine
New drug class approved for migraine prevention.
New Pulmonary Drugs
New approvals for COPD and cystic fibrosis.
Other New Drugs
New drugs for gynecology, cardiology/nephrology, and gastroenterology.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L Windle. FDA Drug Approvals: Primary Care — Year in Review 2018 - Medscape - Jan 15, 2019.